125I versus 103Pd for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial

This publication has 24 references indexed in Scilit:

• A reappraisal of local anesthesia for prostate brachytherapy
  Radiotherapy and Oncology, 2003
• Long‐term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma
  Cancer, 2003
• What is the optimal dose for 125I prostate implants? A dose-response analysis of biochemical control, posttreatment prostate biopsies, and long-term urinary symptoms
  Brachytherapy, 2002
• Biochemical outcome for hormone-naı̈ve intermediate-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external beam radiation
  Brachytherapy, 2002
• The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma
  Radiotherapy and Oncology, 2000
• Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
• Long-term complications with prostate implants: Iodine-125 vs. palladium-103
  Radiation Oncology Investigations, 1999
• Isotope selection for patients undergoing prostate brachytherapy
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
• Follow-up costs after external radiation for low risk prostate cancer
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
• Permanent implants using Au-198, Pd-103 and I-125: Radiobiological considerations based on the linear quadratic model
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1992